BRANZI, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 21.684
EU - Europa 19.134
AS - Asia 17.919
AF - Africa 1.249
SA - Sud America 946
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 20
Totale 60.985
Nazione #
US - Stati Uniti d'America 21.533
SG - Singapore 4.869
VN - Vietnam 4.814
CN - Cina 4.676
GB - Regno Unito 4.469
IT - Italia 4.454
DE - Germania 2.374
SE - Svezia 1.843
UA - Ucraina 1.565
FR - Francia 1.173
HK - Hong Kong 1.103
RU - Federazione Russa 927
IN - India 920
BR - Brasile 677
IE - Irlanda 629
NL - Olanda 417
JP - Giappone 378
EE - Estonia 327
ZA - Sudafrica 320
FI - Finlandia 300
CI - Costa d'Avorio 260
TG - Togo 247
KR - Corea 221
SC - Seychelles 178
BG - Bulgaria 164
JO - Giordania 164
NG - Nigeria 155
CH - Svizzera 144
PH - Filippine 140
AR - Argentina 124
BE - Belgio 100
IR - Iran 89
CA - Canada 86
TH - Thailandia 80
BD - Bangladesh 73
IQ - Iraq 63
PL - Polonia 56
TR - Turchia 52
EC - Ecuador 44
MX - Messico 42
TW - Taiwan 40
GR - Grecia 39
PK - Pakistan 39
AT - Austria 37
ID - Indonesia 34
SA - Arabia Saudita 29
AU - Australia 28
ES - Italia 27
CO - Colombia 25
UZ - Uzbekistan 25
CL - Cile 22
RO - Romania 21
MA - Marocco 20
PY - Paraguay 19
EG - Egitto 17
LB - Libano 17
MY - Malesia 16
AE - Emirati Arabi Uniti 14
PE - Perù 14
CZ - Repubblica Ceca 12
EU - Europa 12
TN - Tunisia 11
AZ - Azerbaigian 10
ET - Etiopia 10
KE - Kenya 10
OM - Oman 10
UY - Uruguay 10
VE - Venezuela 8
A2 - ???statistics.table.value.countryCode.A2??? 7
DK - Danimarca 7
DZ - Algeria 6
IL - Israele 6
HR - Croazia 5
LV - Lettonia 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
DO - Repubblica Dominicana 4
HN - Honduras 4
JM - Giamaica 4
KZ - Kazakistan 4
LT - Lituania 4
MD - Moldavia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
AL - Albania 3
AM - Armenia 3
GE - Georgia 3
MN - Mongolia 3
NP - Nepal 3
PS - Palestinian Territory 3
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
GH - Ghana 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
Totale 60.946
Città #
Southend 3.868
Singapore 3.341
Ashburn 2.014
Fairfield 1.890
Chandler 1.594
San Jose 1.329
Jacksonville 1.100
Hong Kong 1.059
Santa Clara 1.039
Wilmington 1.018
Ho Chi Minh City 981
Houston 974
Woodbridge 953
Princeton 865
Seattle 846
Hanoi 803
Ann Arbor 759
Cambridge 640
Dong Ket 629
Dublin 627
Beijing 617
Hefei 566
Boardman 535
Padova 422
Nanjing 407
Westminster 395
Lauterbourg 383
Milan 378
Tokyo 346
Los Angeles 283
Berlin 270
Helsinki 265
Abidjan 259
Rome 255
Lomé 247
New York 243
Bologna 236
Turin 232
Bremen 229
Saint Petersburg 220
Medford 207
Jinan 202
Buffalo 197
Shenyang 192
Mülheim 175
Amman 162
Sofia 159
Abeokuta 152
Changsha 152
Dallas 146
Seoul 143
Da Nang 140
Nanchang 130
Mahé 128
Haiphong 118
Hebei 118
Frankfurt am Main 116
Bern 115
San Diego 109
Guangzhou 102
Brussels 96
Munich 96
Tianjin 93
Verona 90
Dearborn 87
Shanghai 85
Naples 83
Redondo Beach 83
Jiaxing 82
The Dalles 82
Des Moines 78
Florence 77
São Paulo 76
Zhengzhou 76
Bari 69
Bengaluru 67
Falkenstein 64
Yubileyny 63
Olalla 61
Hangzhou 58
Chicago 54
Haikou 54
Ningbo 51
Norwalk 48
Biên Hòa 44
Taizhou 44
London 43
Redwood City 43
Falls Church 42
Thái Nguyên 41
Monmouth Junction 40
Lanzhou 39
Orem 39
Council Bluffs 37
Düsseldorf 37
Kunming 37
Phoenix 37
Hải Dương 35
Mountain View 34
Ninh Bình 33
Totale 38.478
Nome #
Valutazione italiana del "Minnesota Living with Heart Failure Questionnaire" 1.350
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.084
L'inibitore endogeno della eNOS , la dimetil-arginina simmetrica (ADMA), è un nuovo fattore di rischio di vasculopatia coronarica post trapianto di cuore ed è infulenzato dalla terapia con sirolimus. 422
Sicurezza dell'utilizzo delle statine nel paziente trapiantato di cuore:16 anni di esperienza clinica. 312
Ventricular remodeling in Loeffler endocarditis: Implications for therapeutic decision making. 298
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 298
Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells 270
A randomised study comparing the antiplatelet and antinflammatory effect of clopidogrel 150mg/day versus 75mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: Results from the DOUBLE study. 268
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 259
Usefulness and limitations of (99m)Tc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. 257
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 252
Complicanze del cateterismo cardiaco destro in pazienti con ipertensione polmonare precapillare di grado severo. 251
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 249
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 247
Noninvasive etiologic diagnosis of cardiac amyloidosis using (99m)tc-3,3-diphosphono-1,2-propanodicarboxylic Acid scintigraphy. 243
Detection of Tissue Factor Antigen and Coagulation Activity in Coronary Artery Thrombi Isolated from Patients with ST-Segment Elevation Acute Myocardial Infarction 242
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. 240
Parodoxical contributions of non-compacted and compacted segments to global left ventricular dysfunction in isolated left ventriculat noncompaction 240
A randomised comparison between clopidogrel 150 mg daily maintenance dose versus 75 mg in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention 232
Il test acuto di vasoreattività nei pazienti con ipertensione arteriosa polmonare. 229
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 228
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 226
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 226
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies 223
Amiloidosi ereditaria da mutazione della transtiretina: caratterizzazione dei casi con interessamento cardiaco esclusivo o prevalente 222
Pulmonary Arterial Hypertension associated to connective tissue diseases 221
Effetti emodinamici e funzionali dell'epoprostenolo in associazione agli antagonisti recettoriali dell'endotelina e agli inibitori delle fosfodiesterasi-5 220
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. 219
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 217
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 216
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 210
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension 209
A mechanical device for aortic compliance modulation: In vitro simulation of aortic dissection treatment. 208
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies? 208
Risk Factors for diagnostic delay in acute aortic dissection. 206
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 205
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. 203
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 202
Noninvasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. 201
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 200
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 200
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system 199
Electrocardiographic remodeling during cardiac resynchronization therapy 198
Autocrine and intracrine signaling for cardiogenesis in embryonic stem cells: a clue for the development of novel diffferentiating agents 198
Regressione delle alterazioni elettrocardiografiche indicative di ipertrofia ventricolare destra nei pazienti con ipertensione arteriosa polmonare. 198
Prognostic stratification of patients with right bundle branch block using dobutamine stress echocardiography. 195
Different types of cardiomyopathy associated with isolated ventricular noncompaction 195
Age and heart transplantation: results from a heart failure management unit. 195
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 194
Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms. 192
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 190
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 189
Diagnosi non invasiva di rigetto miocardico acuto: l'analisi armonica dell'ecg coadiuva la valutazione clinica 188
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. 188
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. 188
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 187
Andamento clinico, emodinamico e dei livelli plasmatici dell’NT-pro BNP in pazienti con ipertensione polmonare precapillare 187
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 187
Clinical value of multidetector CT coronary angiography as a preoperative screening test before non-coronary cardiac surgery 185
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 185
Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. 184
Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. 184
Aortoventricular mechanical matching: simulation of normal and pathological conditions 183
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 183
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction 182
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 182
Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction. 182
Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. 181
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 181
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 181
Static and dynamic predictors of adverse events in patients with intermediate cardiopulmonary capacity referred for heart transplantation. 181
La concomitante presenza degli alleli dell'interleuchina-1beta, dell'interleuchina-6 e dell'apolipoproteina E è associata ad un elevato rischio di infarto al miocardio. 180
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 180
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy 180
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 180
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 179
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 178
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 178
Relationship between psychiatric disorders and physical status during the course of a heart transplantation program: a prospective, longitudinal study. 177
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 177
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. 176
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 176
Implantation of cardioverter-defibrillator: Effects on shoulder function. 176
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 176
Genotype-phenotype correlations in amyloidotic cardiomyopathy. 175
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years). 175
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged ³ 75 years) 175
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction 175
Impact of high-sensitivity Troponin T on hospital admission, resources utilization, and outcomes 175
Preprocedural Levels of C-Reactive Protein and Leukocyte Counts Predict 9-Month Mortality After Coronary Angioplasty for the Treatment of Unprotected Left Main Coronary Artery Stenosis. 174
Usefulness of 99-Tc DPD scintigraphy and identification of transthyretin-related cardiac amyloidosis 174
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 174
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 174
Effetti del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare idiopatica, associata e cuore polmonare cronico tromboembolico. 173
Gadolinium enhancement cardiac magnetic resonance in cardiac amyloidosis: clinical, pathophysiologic an hystologic correlations. 173
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 173
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 173
Dilated-Hypokinetic evolution of hypertrophic cardiomyopathy 173
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 173
The endothelin system in pulmonary arterial hypertension. 172
Totale 22.449
Categoria #
all - tutte 149.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.845


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.278 0 0 0 0 0 0 0 0 0 328 311 1.639
2021/20227.253 597 373 492 794 612 458 123 468 241 494 1.307 1.294
2022/20238.307 788 1.077 432 1.137 596 607 198 427 1.421 350 764 510
2023/20242.231 142 340 122 219 201 493 153 120 83 150 103 105
2024/20258.024 331 1.420 697 626 1.592 415 406 225 100 510 166 1.536
2025/202615.683 1.392 1.456 1.590 1.250 2.009 1.089 1.376 976 3.372 1.173 0 0
Totale 61.919